申请人:Merz Pharma GmbH & Co. KGaA
公开号:EP2650284A1
公开(公告)日:2013-10-16
The invention relates to heterocyclic derivatives of formula I as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are mGluR5 modulators and are therefore useful for the control and prevention of acute and/or chronic neurological disorders.
这项发明涉及公式I的杂环衍生物及其药学上可接受的盐。该发明还涉及制备这类化合物的方法。该发明的化合物是mGluR5调节剂,因此对于控制和预防急性和/或慢性神经系统疾病是有用的。